✨ New Arrivals Just Dropped!Explore
$19.50
Original: $65.00
-70%SLU-PP-332 (250mcg) x 60 Tablets—
$65.00
$19.50The Story
- SLU-PP-332 (250mcg) is a potent small-molecule REV-ERB agonist that regulates circadian rhythm and enhances mitochondrial activity, making it a powerful compound for metabolic research.
- This compound has been shown to increase fat oxidation and energy expenditure by activating REV-ERBα/β nuclear receptors, which are central to lipid metabolism and biological clock regulation.
- SLU-PP-332 supports a shift toward greater energy utilization and metabolic efficiency, making it highly relevant for studies targeting obesity, metabolic syndrome, and weight loss.
- By modulating the circadian system, SLU-PP-332 may also play a role in optimizing sleep-wake cycles, hormonal balance, and overall energy homeostasis.
- Ideal for researchers exploring fat loss, endurance, and mitochondrial performance, SLU-PP-332 (250mcg) Tablets x60 provide a targeted approach to investigating advanced metabolic pathways.
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Description
- SLU-PP-332 (250mcg) is a potent small-molecule REV-ERB agonist that regulates circadian rhythm and enhances mitochondrial activity, making it a powerful compound for metabolic research.
- This compound has been shown to increase fat oxidation and energy expenditure by activating REV-ERBα/β nuclear receptors, which are central to lipid metabolism and biological clock regulation.
- SLU-PP-332 supports a shift toward greater energy utilization and metabolic efficiency, making it highly relevant for studies targeting obesity, metabolic syndrome, and weight loss.
- By modulating the circadian system, SLU-PP-332 may also play a role in optimizing sleep-wake cycles, hormonal balance, and overall energy homeostasis.
- Ideal for researchers exploring fat loss, endurance, and mitochondrial performance, SLU-PP-332 (250mcg) Tablets x60 provide a targeted approach to investigating advanced metabolic pathways.
